Even among states that do require the pharmacies to disclose adverse events, Empower Pharmacy hasnt always done so, records show
"I love the relaxing pedicures here
We take the hassle out of the process by accepting insurance and managing prior authorizations, so you can prioritize your health without the burden of paperwork
Download the infographic to see key report statistics, including: 92% of plans cover GLP-1s for type 2 diabetes, while 36% cover GLP-1s for obesity 70% of respondents are moderately or very concerned about off-label use of GLP-1s for type 2 diabetes Among plans that cover GLP-1s for obesity, 81% use prior authorization and 58% have a BMI requirement The most commonly selected top reasons for excluding GLP-1s for obesity from coverage are that the drugs are too expensive to cover for all members for whom they would be prescribed (38%) and considering these to be lifestyle drugs which are excluded from coverage (27%)
Earlier this week the website was still down, with a plain text announcement simply saying it was "coming soon." Questions remained about how patients could access drugs, if the pricing would scale based on insurance, and if commercial insurance could be used at all